Eruption of purpura compatible with vasculitis and torasemide
Sanfélix Genovés, J.; Benlloch Nieto, H.; Verdú Tárraga, R.; Costa Alcaraz, A.M.
Atencion Primaria 21(4): 252-253
1998
ISSN/ISBN: 0212-6567 PMID: 9607256 Document Number: 487149
Document emailed within 1 workday
Related Documents
Porrello, M.; Gesù, M.; Ciaccio, C. 1998: Schoenlein-Henoch purpura following Kawasaki syndrome: a predisposition to vasculitis? La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 20(1): 71-73Mitamura, T.; Tanimoto, K. 1978: Clinicopathological studies of diseases associated with vasculitis--hypersensitivity angiitis and Schönlein-Henoch purpura Nihon Rinsho. Japanese Journal of Clinical Medicine 36(4): 791-797
Callen, J.P. 2000: Are Henoch-Schönlein purpura and hypersensitivity vasculitis in adults truly distinct entities? a dermatologist's perspective Clinical and Experimental Rheumatology 18(6): 659-660
Piette, W.W.; Stone, M.S. 1989: A cutaneous sign of IgA-associated small dermal vessel leukocytoclastic vasculitis in adults (Henoch-Schönlein purpura) Archives of Dermatology 125(1): 53-56
Isedeh, P.; Lim, H.W. 2013: Polymorphous light eruption presenting as pinhead papular eruption on the face Journal of Drugs in Dermatology: Jdd 12(11): 1285-1286
Ostertag, J.U. 1998: Recurrent postherpetic erythema multiforme presenting as a polymorphous light eruption and 'juvenile spring eruption Nederlands Tijdschrift Voor Geneeskunde 142(49): 2711-2712
Escolar, M.; Quetglas, E.G.; Honorato, J. 1996: Torasemide Revista de Medicina de la Universidad de Navarra 40(4): 45-52
Klinke, R.; Mertens, M. 1988: Quantitative assessment of torasemide ototoxicity Arzneimittel-Forschung 38(1a): 153-155
Acuña, C. 2010: Update: prolonged-release torasemide Drugs of Today 46 Suppl E: 1-15
Clerckx-Braun, F.; Lesne, M. 1980: Pharmacokinetic study of a new diuretic: torasemide in man Journal de Pharmacie de Belgique 35(3): 223-224
Lamprecht, P.; Moubayed, P.; Donhuijsen, K.; Gause, A.; Gross, W.L. 2001: Vasculitis of adnexa, greater omentum and gallbladder as abdominal manifestations of cryoglobulinemic vasculitis Clinical and Experimental Rheumatology 19(1): 112-113
Lameire, N.; Dodion, L. 1988: Acute and chronic effects of torasemide in healthy volunteers Arzneimittel-Forschung 38(1a): 167-171
Lie, J.T. 1987: Coronary vasculitis. a review in the current scheme of classification of vasculitis Archives of Pathology and Laboratory Medicine 111(3): 224-233
Fey, M.F.; Beck, E.A. 1986: Psychogenic purpura, idiopathic thrombocytopenic purpura, and platelet dysfunction in the same patient Journal of Clinical Psychiatry 47(7): 386-387
Ambriz-Fernández, R.; Sinco-Angeles, A.; Avilés-Miranda, A.; Chávez-Vela, J.; Pizzuto-Chávez, J. 1983: Idiopathic thrombocytopenic purpura in 225 adult cases. use of delayed action prednisone in chronic purpura Gaceta Medica de Mexico 119(4): 164-168
Reyes, A.J. 1988: Formal comparison of the antihypertensive effects of torasemide and other diuretics by the Montevideo mathematical model Arzneimittel-Forschung 38(1a): 194-199
Spannbrucker, N.; Achhammer, I.; Metz, P.; Glocke, M. 1988: Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension Arzneimittel-Forschung 38(1a): 190-193
Klein, P.J.; Löhrs, U.; Hübner, G.; Lennartz, K.J. 1971: Moschcowitz-syndrome. Common synonyms: thrombotic-thrombocytic purpura; thrombohemolytic thrombocytopenic purpura, thrombotic microangiopathy Die Medizinische Welt 23: 949-953
Lamprecht, P.; Moosig, F.; Gause, A.; Herlyn, K.; Gross, W.L. 2000: Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis Clinical and Experimental Rheumatology 18(3): 319-325
Van Servellen, G.M.; Mowry, M.M. 1985: DRGs and primary nursing: are they compatible? Journal of Nursing Administration 15(4): 32-36